APA (7th ed.) Citation

Gillot, C., Bayart, J., Maloteau, V., Dogné, J., Douxfils, J., & Favresse, J. Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated Population. Wiley.

Chicago Style (17th ed.) Citation

Gillot, Constant, Jean-Louis Bayart, Vincent Maloteau, Jean-Michel Dogné, Jonathan Douxfils, and Julien Favresse. Evaluation of Neutralizing Capacity of Tixagevimab Plus Cilgavimab (AZD7442) Against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated Population. Wiley.

MLA (9th ed.) Citation

Gillot, Constant, et al. Evaluation of Neutralizing Capacity of Tixagevimab Plus Cilgavimab (AZD7442) Against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated Population. Wiley.